Innovating Works
HORIZON-JU-GH-EDCTP3-2024...
HORIZON-JU-GH-EDCTP3-2024-01-05-two-stage: New tools, technologies and approaches for vector control in sub-Saharan Africa
Expected Impact:Activities funded under the 2024 work programme of the Global Health EDCTP3 JU calls for proposals should contribute to:
Sólo fondo perdido 0 €
European
This call is closed This line is already closed so you can't apply. It closed last day 04-04-2024.
Hace más de 13 mes(es) del cierre y aún no tenemos información sobre los proyectos financiados, no parece que se vaya a publicar esta información.
Presentation: Consortium Consortium: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Minimum number of participants.
This aid finances Proyectos:

Expected Impact:Activities funded under the 2024 work programme of the Global Health EDCTP3 JU calls for proposals should contribute to:

reduce the individual, social, and economic burdens of infectious diseases in sub-Saharan Africa through the development and uptake of new or improved interventions, andincrease health security in sub-Saharan Africa and globally by reducing the risk of outbreaks and pandemics and enhancing national and regional capacity to address antimicrobial resistance.Progressing towards the achievement of SDG3 ‘Ensure healthy lives and promote well-being for all at all ages’ in sub-Saharan African (SSA) countries;Enable the implementation of the short- and medium-term actions foreseen by the AU EU Innovation Agenda (adopted in July 2023) in the area of public health and the EU Global Health Strategy (November 2022); Improve equitable access to a full range of essential health services from health promotion to disease prevention and affordable quality treatment, rehabilitation and palliative care to fight communicable diseases;Expand partnerships based on equal footing, co-ownership, mutual interest and strategic priorities; Provide evidence... see more

Expected Impact:Activities funded under the 2024 work programme of the Global Health EDCTP3 JU calls for proposals should contribute to:

reduce the individual, social, and economic burdens of infectious diseases in sub-Saharan Africa through the development and uptake of new or improved interventions, andincrease health security in sub-Saharan Africa and globally by reducing the risk of outbreaks and pandemics and enhancing national and regional capacity to address antimicrobial resistance.Progressing towards the achievement of SDG3 ‘Ensure healthy lives and promote well-being for all at all ages’ in sub-Saharan African (SSA) countries;Enable the implementation of the short- and medium-term actions foreseen by the AU EU Innovation Agenda (adopted in July 2023) in the area of public health and the EU Global Health Strategy (November 2022); Improve equitable access to a full range of essential health services from health promotion to disease prevention and affordable quality treatment, rehabilitation and palliative care to fight communicable diseases;Expand partnerships based on equal footing, co-ownership, mutual interest and strategic priorities; Provide evidence for informed health policies and guidelines within public health systems in SSA and at international level;Enhance sustainable global scientific collaboration in health research and international cooperation across SSA;Develop novel, innovative HIV therapeutics for reducing the disease burden of HIV in SSAResearch on existing Malaria vaccines and development of new promising candidatesAccelerating development and integration of therapeutics against neglected tropical diseases (NTDs) in SSA;Tackle Antimicrobial Resistance (AMR) through R&D in novel and existing antimicrobialsDevelop new tools, technologies and approaches for vector control in SSA;Develop innovative digital health solutions for SSA.Build appropriate local capacity. Expected Outcome:Proposals under this topic should aim to deliver results that are directed, tailored towards, and contributing to the development and evaluation of tools, technologies and approaches for vector-borne diseases, including vector control and disease management technologies.

Scope:Background:

Vector-borne diseases[1] account for more than 17% of all infectious diseases, causing more than 700000 deaths annually. They are human illnesses caused by parasites, virus and bacteria that are transmitted by vectors, living organisms that can transmit infectious pathogens between humans or from animals to humans. Most vectors are bloodsucking insects, such as mosquitos and ticks.

The burden of vector-borne diseases is highest in tropical and subtropical areas, and they disproportionately affect the poorest populations. Continuing urbanization and climate change are driving the expansion of the geographic range in which many of these vectors can thrive. Increasing numbers of autochthonous cases have also been reported from European countries2.

The "Global Vector Control Response (GVCR) 2017–2030", approved by the World Health Assembly in 2017, supports the implementation of approaches to vector control that will enable the achievement of disease-specific national and global goals and contribute to achievement of the Sustainable Development Goals and Universal Health Coverage.

Many of vector-borne diseases are preventable, through protective measure and community mobilisation. Vaccines can help prevent some vector-borne diseases, such as yellow fever, Japanese encephalitis, tick-borne encephalitis. Another crucial element in reducing the burden of vector-borne diseases is behavioural change. Access to water and sanitation is another very important factor in disease control and elimination. However, not all vector-borne diseases have effective vaccines available and/or can be effectively prevented.

Scope:

Within the scope of this topical area should be innovative interventions that target any vector-borne disease including transmission through mosquitos, ticks, flies, fleas, lice, aquatic snails, and bugs.

Proposals submitted to this call topic must focus on vectors responsible for the transmission of one or more diseases with the scope of the Global Health EDCTP3 JU scope (see Table 1). To that end, the following diseases are considered as relevant to this call topic:

Chikungunya, Dengue, Lymphatic filariasis, Rift Valley fever, Yellow Fever, Schistosomiasis, Onchocerciasis, Plague, Leishmaniasis, Crimean-Congo haemorrhagic fever, Sleeping sickness and malaria.

Table 1: Vector-Borne infectious diseases in the scope of the Global Health EDCTP3 JU

Vector

Disease caused

Type of pathogen

GH EDCTP3 JU scope category

Mosquito

Aedes

Chikungunya

Virus

NTDs

Dengue

Virus

NTDs

Lymphatic filariasis

Parasite

NTDs

Rift Valley fever

Virus

EIDs

Yellow Fever

Virus

EIDs

Anopheles

Lymphatic filariasis

Parasite

NTDs

Malaria

Parasite

PRDs

Culex

Lymphatic filariasis

Parasite

NTDs

Aquatic snails

Schistosomiasis (bilharziasis)

Parasite

NTDs

Blackflies

Onchocerciasis (river blindness)

Parasite

NTDs

Fleas

Plague (transmitted from rats to humans)

Bacteria

EIDs

Sandflies

Leishmaniasis

Parasite

NTDs

Ticks

Crimean-Congo haemorrhagic fever

Virus

EIDs

Tsetse flies

Sleeping sickness (African trypanosomiasis)

Parasite

NTDs

Intervention could include novel or improved approaches of:

Vector traps;Genetic manipulation;Sterilization agents;Reduced pathogen transmission by microorganisms;Insecticide-treated nets (ITN);Chemosensory interference, specifically spatial repellents, bait station and repel and lure strategies;Systemic insecticides and endectocides;Improvements in housing/urbanisation;Monitoring and surveillance tools. Emphasis should be given to interventions at the community level and to the barriers of vector-control in the health system. Initiatives with linkage to climate change impact are welcome.

Applicants are reminded of the expectation that proposals should come from research consortia with a strong representation of institutions and researchers from sub-Saharan African countries, including involvement of Franco/Lusophone countries if possible. Applicants are also reminded of the expectation of reaching out to organisations in countries with relatively lower research capacities.

[1] Vector-borne diseases (who.int) and Disease vectors (europa.eu)

see less

Temáticas Obligatorias del proyecto: Temática principal:
ExpectedOutcome:Proposals under this topic should aim to deliver results that are directed, tailored towards, and contributing to the development and evaluation of tools, technologies and approaches for vector-borne diseases, including vector control and disease management technologies. ExpectedOutcome:Proposals under this topic should aim to deliver results that are directed, tailored towards, and contributing to the development and evaluation of tools, technologies and approaches for vector-borne diseases, including vector control and disease management technologies.

Healthcare Technology Infectious Diseases Public Health

Consortium characteristics

Scope European : The aid is European, you can apply to this line any company that is part of the European Community.
Tipo y tamaño de organizaciones: The necessary consortium design for the processing of this aid needs:

characteristics of the Proyecto

Requisitos de diseño: *Presupuesto para cada participante en el proyecto
Requisitos técnicos: Expected Impact:Activities funded under the 2024 work programme of the Global Health EDCTP3 JU calls for proposals should contribute to: Expected Impact:Activities funded under the 2024 work programme of the Global Health EDCTP3 JU calls for proposals should contribute to:
Financial Chapters: The chapters of financing expenses for this line are:
Personnel costs.
Expenses related to personnel working directly on the project are based on actual hours spent, based on company costs, and fixed ratios for certain employees, such as the company's owners.
Subcontracting costs.
Payments to external third parties to perform specific tasks that cannot be performed by the project beneficiaries.
Purchase costs.
They include the acquisition of equipment, amortization, material, licenses or other goods and services necessary for the execution of the project
Other cost categories.
Miscellaneous expenses such as financial costs, audit certificates or participation in events not covered by other categories
Indirect costs.
Overhead costs not directly assignable to the project (such as electricity, rent, or office space), calculated as a fixed 25% of eligible direct costs (excluding subcontracting).
Madurez tecnológica: The processing of this aid requires a minimum technological level in the project of TRL 4:. Los componentes que integran determinado proyecto de innovación han sido identificados y se busca establecer si dichos componentes individuales cuentan con las capacidades para actuar de manera integrada, funcionando conjuntamente en un sistema. + info.
TRL esperado:

Characteristics of financing

Intensidad de la ayuda: Sólo fondo perdido + info
Lost Fund:
For the eligible budget, the intensity of the aid in the form of a lost fund may reach as minimum a 100%.
The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations. The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations.
Guarantees:
does not require guarantees
No existen condiciones financieras para el beneficiario.

Additional information about the call

incentive effect: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
non -competitive competitive Very competitive
We do not know the total budget of the line
minimis: Esta línea de financiación NO considera una “ayuda de minimis”. You can consult the regulations here.
Certificado DNSH: Los proyectos presentados a esta línea deben de certificarse para demostrar que no causan perjuicio al medio ambiente. + info

other advantages

SME seal: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
deduction R&D+i:
0% 25% 50% 75% 100%
Ark + info
HORIZON-JU-GH-EDCTP3-2024-01-two-stage New tools, technologies and approaches for vector control in sub-Saharan Africa Expected Impact:Activities funded under the 2024 work programme of the Global Health EDCTP3 JU calls for proposals should contribute to: re...
Sin info.
HORIZON-JU-GH-EDCTP3-2024-01-05-two-stage New tools, technologies and approaches for vector control in sub-Saharan Africa
en consorcio: Expected Impact:Activities funded under the 2024 work programme of the Global Health EDCTP3 JU calls for proposals should contribute to: re...
Cerrada does 1 year | next call scheduled for the month of